https://www.selleckchem.com/products/sr-18292.html
Primary mediastinal B cell lymphoma is a rare entity and often should be promptly treated as a hematological emergency The initial treatment decision is crucial for the management of this disease. An observational retrospective study was conducted with the aim to improve information on treatment and outcomes of primary mediastinal B cell lymphoma in real practice. After 12 cycles of MACOP-B regimen (methotrexate, doxorubicin, cyclophosphamide, vincristine, bleomycin , and prednisone) with or without rituximab, 120 patients out of 151 (
Like
Comment
Share
